Understanding ACTA2: A Potential Drug Target for Various Diseases
Understanding ACTA2: A Potential Drug Target for Various Diseases
Actin alpha 2 (ACTA2) is a protein that is expressed in various tissues throughout the body, including muscle, heart, and brain. It is a key component of the cytoskeleton, which is the structure that gives shape to the cell. ACTA2 plays a crucial role in the regulation of cell division, and is also involved in the development and maintenance of muscle mass.
As a drug target, ACTA2 is of great interest to researchers because of its potential to treat a variety of diseases. For example, ACTA2 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and prostate cancer. It has also been linked to a number of cardiovascular diseases, including heart failure, arrhythmia, and hypertension.
In addition to its potential as a drug target, ACTA2 has also been identified as a potential biomarker for a variety of diseases. The cytoskeleton is a complex structure that is involved in the mechanical properties of cells, and it is thought to play a key role in the regulation of cell function. The actin filament, which is a key component of the cytoskeleton, is composed of a protein called actinin. Activated actinin (ACTN) is the protein that forms the active portion of the filament.
ACTA2 is thought to be involved in the regulation of the actin filament, and it is possible that it plays a key role in the regulation of cell division and the development of the cytoskeleton. This is an area of ongoing research, and more studies are needed to fully understand the role of ACTA2 in these processes.
Drugs that target ACTA2 have the potential to treat a variety of diseases. For example, inhibitors of the protein have been shown to be effective in treating breast cancer, and inhibitors of ACTA2 have been shown to be effective in treating heart failure and hypertension. Additionally, ACTA2 has been shown to be involved in the regulation of the contractility of smooth muscles, which are the muscles that propel blood through the circulatory system. This suggests that ACTA2 may be a useful target for treating conditions that involve the regulation of smooth muscle contractions, such as heart failure.
In conclusion, ACTA2 is a protein that is expressed in various tissues throughout the body and plays a crucial role in the regulation of cell division and the development of the cytoskeleton. It is of great interest to researchers because of its potential to treat a variety of diseases, including cancer and cardiovascular disease. Further research is needed to fully understand the role of ACTA2 in these processes and to identify potential biomarkers for this protein.
Protein Name: Actin Alpha 2, Smooth Muscle
Functions: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells
More Common Targets
ACTA2-AS1 | ACTB | ACTBL2 | ACTBP12 | ACTBP2 | ACTBP3 | ACTBP8 | ACTBP9 | ACTC1 | ACTE1P | ACTG1 | ACTG1P1 | ACTG1P10 | ACTG1P12 | ACTG1P17 | ACTG1P20 | ACTG1P22 | ACTG1P25 | ACTG1P4 | ACTG2 | Actin | Activating signal cointegrator 1 complex protein | Activin receptor type 2 (nonspecifed subtype) | ACTL10 | ACTL6A | ACTL6B | ACTL7A | ACTL7B | ACTL8 | ACTL9 | ACTMAP | ACTN1 | ACTN1-DT | ACTN2 | ACTN3 | ACTN4 | ACTR10 | ACTR1A | ACTR1B | ACTR2 | ACTR3 | ACTR3B | ACTR3BP2 | ACTR3BP5 | ACTR3BP6 | ACTR3C | ACTR5 | ACTR6 | ACTR8 | ACTRT1 | ACTRT2 | ACTRT3 | ACVR1 | ACVR1B | ACVR1C | ACVR2A | ACVR2B | ACVR2B-AS1 | ACVRL1 | ACY1 | ACY3 | Acyl-CoA dehydrogenase (ACAD) | Acyl-CoA Synthetase Short-Chain | ACYP1 | ACYP2 | ADA | ADA2 | ADA2A-containing complex (ATAC) | ADAD1 | ADAD2 | ADAL | ADAM10 | ADAM11 | ADAM12 | ADAM15 | ADAM17 | ADAM18 | ADAM19 | ADAM1A | ADAM1B | ADAM2 | ADAM20 | ADAM20P1 | ADAM21 | ADAM21P1 | ADAM22 | ADAM23 | ADAM28 | ADAM29 | ADAM30 | ADAM32 | ADAM33 | ADAM3A | ADAM5 | ADAM6 | ADAM7 | ADAM7-AS1 | ADAM7-AS2 | ADAM8 | ADAM9